Kelley Haley
APLA Health(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Brain Metastases and Treatment, Testicular diseases and treatments, Head and Neck Surgical Oncology
Most-Cited Works
- → Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience(2013)108 cited
- → Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on “Head Start” III: a multi-institutional, prospective clinical trial(2020)91 cited
- → Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial(2013)78 cited
- → Outcome of young children with high‐grade glioma treated with irradiation‐avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials(2016)40 cited
- → Outcome of infants and young children with newly diagnosed medulloblastoma treated on Head Start III protocol.(2011)33 cited
- → Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the ‘Head Start’ trials, 1991–2009(2016)18 cited
- → Outcome of Head Start III multinational protocol for newly diagnosed central nervous system (CNS) primitive neuroectodermal tumors (pnet) of young children.(2011)6 cited
- → P11.02 Long-term Outcome of Infants and Young Children with Newly Diagnosed Non-Nodular/Desmoplastic Medulloblastoma Treated on “Head Start” III Protocol(2017)4 cited
- → PRELIMINARY RESULTS OF A PROSPECTIVE FEASIBILITY PILOT STUDY OF "GEMPOX" (GEMCITABINE, OXALIPLATIN, AND PACLITAXEL) IN PEDIATRIC AND ADULT PATIENTS WITH REFRACTORY OR RECURRENT CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCT): THE INTERNATIONAL CNS GCT CONSORTIUM TRIAL, CNS GCT-4(2014)4 cited
- → OS02.4 Long-term Outcome of Infants and Young Children with Newly Diagnosed Nodular Desmoplastic Medulloblastoma Treated on “Head Start” III Protocol(2017)2 cited